Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcela F Pasetti

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
Protein Expression and Purification|November 20, 2015
Simple method for purification of enterotoxigenic Escherichia coli fimbriaeBrittany Curtis, Christen Grassel, Rachel S Laufer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 studyVadrevu Krishna Mohan, Vineeth Varanasi, Anit Singh, et al.
Human Gene Therapy|May 30, 2008
Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimenKarina Ramirez, Eileen M Barry, Jeffrey Ulmer, et al.
Microbial Pathogenesis|January 26, 2010
A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infectionPetra C F Oyston, Gabriela Mellado-Sanchez, Marcela F Pasetti, et al.
Pathogens and Disease|April 24, 2016
Characterization of a multicomponent live, attenuated Shigella flexneri vaccineBreOnna C DeLaine, Tao Wu, Christen L Grassel, et al.
Infection and Immunity|August 3, 2011
Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strainsSharon M Tennant, Jin-Yuan Wang, James E Galen, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural MaliMilagritos D Tapia, Samba O Sow, Sandra Medina-Moreno, et al.
Emerging Microbes & Infections|August 1, 2019
Pregnancy level of estradiol attenuated virus-specific humoral immune response in H5N1-infected female mice despite inducing anti-inflammatory protectionCourtney L Finch, Anding Zhang, Martina Kosikova, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2010
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humansRezwanul Wahid, Marcela F Pasetti, Milton Maciel, et al.
Vaccine|November 25, 2010
A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancerAlejandrina Vendrell, María J Gravisaco, Marcela F Pasetti, et al.
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Protein Expression and Purification|November 20, 2015
Simple method for purification of enterotoxigenic Escherichia coli fimbriaeBrittany Curtis, Christen Grassel, Rachel S Laufer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 studyVadrevu Krishna Mohan, Vineeth Varanasi, Anit Singh, et al.
Human Gene Therapy|May 30, 2008
Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimenKarina Ramirez, Eileen M Barry, Jeffrey Ulmer, et al.
Microbial Pathogenesis|January 26, 2010
A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infectionPetra C F Oyston, Gabriela Mellado-Sanchez, Marcela F Pasetti, et al.
Pathogens and Disease|April 24, 2016
Characterization of a multicomponent live, attenuated Shigella flexneri vaccineBreOnna C DeLaine, Tao Wu, Christen L Grassel, et al.
Infection and Immunity|August 3, 2011
Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strainsSharon M Tennant, Jin-Yuan Wang, James E Galen, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural MaliMilagritos D Tapia, Samba O Sow, Sandra Medina-Moreno, et al.
Emerging Microbes & Infections|August 1, 2019
Pregnancy level of estradiol attenuated virus-specific humoral immune response in H5N1-infected female mice despite inducing anti-inflammatory protectionCourtney L Finch, Anding Zhang, Martina Kosikova, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2010
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humansRezwanul Wahid, Marcela F Pasetti, Milton Maciel, et al.
Vaccine|November 25, 2010
A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancerAlejandrina Vendrell, María J Gravisaco, Marcela F Pasetti, et al.
Pageof 18